Você procurou por: biovitrum (Espanhol - Inglês)

biovitrum ab (publ)
biovitrum ab (publ)

norge biovitrum ab (publ) c. j.
norge biovitrum ab (publ) c. j.

biovitrum bv lindhagensgatan 133 se-11276 estocolmo suecia
biovitrum bv lindhagengatan 133 se-11276 stockholm sweden

swedish orphan biovitrum international ab se-112 76 estocolmo
swedish orphan biovitrum international ab se-112 76 stockholm

swedish orphan biovitrum ab (publ) se-112 76 estocolmo
se-112 76 stockholm

biovitrum ab (publ) strandbergsgatan 49 se-11276 estocolmo suecia
biovitrum ab (publ) strandbergsgatan 49 se-11276 stockholm sweden

swedish orphan biovitrum ab (publ), se-112 76 estocolmo, suecia
swedish orphan biovitrum ab (publ), se-112 76 stockholm, sweden

luxembourg/luxemburg swedish orphan biovitrum ltd tél/tel: + 44 1638 72 23
luxembourg/luxemburg swedish orphan biovitrum ltd tél/tel: + 44 1638 72 23 80

desde el 15 de diciembre de 2008 biovitrum ab es la titular de la autorización de kineret sobre la indicación de adultos con artritis reumatoide.
since 15 december 2008 swedish orphan biovitrum ab is the global market authorisation holder for kineret on the indication adult rheumatoid arthritis.

biovitrum ab (publ) berzelius väg 8, s-112 76 stockholm tel: + 46 8 697 2000
Ísland biovitrum ab (publ) berzelius väg 8, s-112 76 stockholm tel: + 46 8 697 2000

sverige biovitrum ab (publ) berzelius väg 8 s-112 76 stockholm tel: + 46 8 697 2000
sverige biovitrum ab (publ) berzelius väg 8 s-112 76 stockholm tel: + 46 8 697 2000

danmark biovitrum ab (publ) næsseslottet dronninggårds allé 136 dk-2840 holte tlf: + 46 8 697 2000
danmark biovitrum ab (publ) næsseslottet

swedish orphan biovitrum a/s Τel: +39 0521 19 111 e-mail: mail.it@sobi.com
swedish orphan biovitrum a/s tlf: + 45 32 96 68 69 e-mail: mail.dk@sobi.com

swedish orphan biovitrum a/s tlf: + 45 32 96 68 69 e-mail: mail.dk@sobi.com
swedish orphan biovitrum a/s tlf: +49 89 55066760 e-mail: mail.dk@sobi.com

suomi/ finland biovitrum ab (publ) pakkalankuja 7 fin-01510 vantaa puh/ tel: + 46 8 697 2000
suomi/ finland biovitrum ab (publ) pakkalankuja 7 fin-01510 vantaa

se entregaron dos premios eurordis a la empresa: uno a la sueca orphan biovitrum (sobi), por la excelencia y consistencia de su trabajo en el desarrollo de tratamientos para las enfermedades raras y su historial en la creación de un exitoso diálogo con las comunidades de pacientes; y otro a orphan europe, por el sólido portfolio vía de información sobre los tratamientos de las enfermedades raras, y por su firme compromiso con las organizaciones de pacientes.
two eurordis company awards were presented: one to swedish orphan biovitrum (sobi), for the excellence and consistency of their work in developing treatments for rare diseases and their track record of creating successful dialogue with patient communities; and the other to orphan europe, for their robust portfolio and strong pipeline of rare disease treatments, as well as for their committed engagement with patient organisations.